Canopy Growth (CGC) Cash from Investing Activities (2019 - 2025)

Canopy Growth's (CGC) quarterly Cash from Investing Activities came in at $3.8 million in Q4 2025, up 118.72% year-on-year from $1.7 million in Q4 2024, and down 68.9% quarter-over-quarter from $12.2 million in Q3 2025.

Canopy Growth (CGC) Cash from Investing Activities (2019 - 2025) Analysis & Trends

Canopy Growth has disclosed Cash from Investing Activities across 7 years of filings, most recently posting $3.8 million for Q4 2025.

  • Cash from Investing Activities for Q4 2025 came in at $3.8 million, up 118.72% year-over-year; the trailing twelve-month figure through Dec 2025 was $24.1 million (up 178.73% YoY), and the FY2025 annual result was -$33.3 million, down 120.44% from the prior year.
  • Cash from Investing Activities came in at $3.8 million for Q4 2025 at Canopy Growth, down from $12.2 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $260.8 million in Q3 2021 to a low of -$438.7 million in Q1 2021.
  • The 5-year median for Cash from Investing Activities is $8.4 million (2024), against an average of $11.1 million.
  • Across the five-year window, Cash from Investing Activities slumped 788.29% in 2021 and soared 695.51% in 2022, its largest moves.
  • Canopy Growth's Cash from Investing Activities stood at -$19.7 million in 2021, then surged by 695.51% to $117.2 million in 2022, then tumbled by 111.11% to -$13.0 million in 2023, then slumped by 55.02% to -$20.2 million in 2024, then surged by 118.72% to $3.8 million in 2025.
  • The last three Cash from Investing Activities figures came in at $3.8 million (Q4 2025), $12.2 million (Q3 2025), and -$508807.3 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -2.08 Bn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 25.99 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -15.45 Mn
10 Canopy Growth 11.27 Mn -137.42 Mn 15.39 Mn 3.78 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.78 Mn
Dec 31, 2025 3.78 Mn
Sep 30, 2025 12.16 Mn
Sep 30, 2025 12.16 Mn
Jun 30, 2025 -508,807.31
Jun 30, 2025 -508,807.31
Mar 31, 2025 8.65 Mn
Mar 31, 2025 8.65 Mn
Dec 31, 2024 -20.19 Mn
Dec 31, 2024 -20.19 Mn
Sep 30, 2024 8.21 Mn
Sep 30, 2024 8.21 Mn
Jun 30, 2024 -31.58 Mn
Jun 30, 2024 -31.58 Mn
Mar 31, 2024 12.98 Mn
Mar 31, 2024 12.98 Mn
Dec 31, 2023 -13.03 Mn
Dec 31, 2023 -13.03 Mn
Sep 30, 2023 57.78 Mn
Sep 30, 2023 57.78 Mn